Zhang Q - Search Results

1

Evidence of Residual Ongoing Viral Replication in Chronic Hepatitis B Patients Successfully Treated With Nucleos(t)ide Analogues.

Yu T, Zhang M, Zhang H, Zheng J, Shen C, Jiang N, Zou L, Wang J, Yu Y, Zhang Q, Yu S, Huang Y, Huang Y, Zhang J, Qiu C, Zhang W, Meng Z. Yu T, et al. Among authors: zhang m, zhang q, zhang w, zhang j, zhang h. J Infect Dis. 2023 Mar 1;227(5):675-685. doi: 10.1093/infdis/jiac493. J Infect Dis. 2023. PMID: 36546708

2

Histological response to combination therapy with nucleos(t)ide analogs and peginterferon alpha in treatment-naïve chronic hepatitis B patients.

Zhang Q, Li G, Yu Y, Qiu C, Zheng J, Zhang H, Zhang M, Song Z, Yang Y, Du X, Hong J, Lu J, Li N, Tang Q, Xu L, Wang X, Huang Y, Zhang J, Chen Z, Zhang W. Zhang Q, et al. Among authors: zhang m, zhang w, zhang j, zhang h. J Viral Hepat. 2019 Jul;26 Suppl 1:59-68. doi: 10.1111/jvh.13153. J Viral Hepat. 2019. PMID: 31380588

3

Histological responses of peginterferon alpha add-on therapy in patients with chronic hepatitis B with advanced liver fibrosis after long-term nucleos(t)ide analog treatment.

Li G, Zhang Q, Yu Y, Qiu C, Zhang H, Zhang M, Song Z, Yang Y, Hong J, Lu J, Li N, Tang Q, Xu L, Wang X, Zhang W, Chen Z. Li G, et al. Among authors: zhang m, zhang q, zhang w, zhang h. J Viral Hepat. 2019 Jul;26 Suppl 1:50-58. doi: 10.1111/jvh.13152. J Viral Hepat. 2019. PMID: 31380590

4

The role of bone marrow metagenomics next-generation sequencing to differential diagnosis among visceral leishmaniasis, histoplasmosis, and talaromycosis marneffei.

Zhang HC, Zhang QR, Ai JW, Cui P, Wu HL, Zhang WH, Wang T. Zhang HC, et al. Int J Lab Hematol. 2020 Apr;42(2):e52-e54. doi: 10.1111/ijlh.13103. Epub 2019 Oct 8. Int J Lab Hematol. 2020. PMID: 31592568 No abstract available.

5

Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis.

Li Y, Wang J, Yu Y, Qiu C, Li Z, Ling Q, Zhang G, Li L, Gong Y, Lu Q, Cao L, Gu T, Wang X, Zhang M, Zhang Q, Zhang H, Xu B, Shao L, Pu Y, Zhang W. Li Y, et al. Among authors: zhang m, zhang q, zhang g, zhang w, zhang h. Liver Int. 2020 Oct;40(10):2377-2384. doi: 10.1111/liv.14479. Epub 2020 Jun 30. Liver Int. 2020. PMID: 32304160

6

Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational study.

Li Y, Zhou X, Li T, Chan S, Yu Y, Ai JW, Zhang H, Sun F, Zhang Q, Zhu L, Shao L, Xu B, Zhang W. Li Y, et al. Among authors: zhang q, zhang w, zhang h. Emerg Microbes Infect. 2020 Dec;9(1):1869-1877. doi: 10.1080/22221751.2020.1807885. Emerg Microbes Infect. 2020. PMID: 32795143 Free PMC article.

7

Recombinant protein subunit vaccine booster following two-dose inactivated vaccines dramatically enhanced anti-RBD responses and neutralizing titers against SARS-CoV-2 and Variants of Concern.

Ai J, Zhang H, Zhang Q, Zhang Y, Lin K, Fu Z, Song J, Zhao Y, Fan M, Wang H, Qiu C, Zhou Y, Zhang W. Ai J, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Cell Res. 2022 Jan;32(1):103-106. doi: 10.1038/s41422-021-00590-x. Epub 2021 Nov 23. Cell Res. 2022. PMID: 34815511 Free PMC article. No abstract available.

8

Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost.

Ai J, Zhang H, Zhang Y, Lin K, Zhang Y, Wu J, Wan Y, Huang Y, Song J, Fu Z, Wang H, Guo J, Jiang N, Fan M, Zhou Y, Zhao Y, Zhang Q, Liu Q, Lv J, Li P, Qiu C, Zhang W. Ai J, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Emerg Microbes Infect. 2022 Dec;11(1):337-343. doi: 10.1080/22221751.2021.2022440. Emerg Microbes Infect. 2022. PMID: 34935594 Free PMC article.

9

Safety and immunogenicity of a third-dose homologous BBIBP-CorV boosting vaccination: interim results from a prospective open-label study.

Ai J, Zhang Y, Zhang H, Zhang Q, Fu Z, Lin K, Song J, Zhao Y, Fan M, Wang H, Zhou Y, Chen X, Qiu C, Zhang W. Ai J, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Emerg Microbes Infect. 2022 Dec;11(1):639-647. doi: 10.1080/22221751.2022.2025746. Emerg Microbes Infect. 2022. PMID: 35034582 Free PMC article.

10

Natural History of and Dynamic Changes in Clinical Manifestation, Serology, and Treatment of Brucellosis, China.

Wang H, Liu H, Zhang Q, Lu X, Li D, Zhang H, Wang YA, Zheng R, Zhang Y, Fu Z, Lin K, Qiu C, Wang YO, Gu Y, Ai J, Zhang W. Wang H, et al. Among authors: zhang q, zhang w, zhang h, zhang y. Emerg Infect Dis. 2022 Jul;28(7):1460-1465. doi: 10.3201/eid2807.211766. Emerg Infect Dis. 2022. PMID: 35731038 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

64,161 results

Search Page